Humana Reports 26% Revenue Increase and Improves Medicare Advantage Ratings
Humana has reported a significant financial milestone with a 26% increase in third-quarter revenue, reaching $41.2 billion compared to the previous year's $32.6 billion, signaling a robust recovery in its operational strategy.
This fiscal report comes as the company undergoes a comprehensive transformation in the broker market, following a two-year strategic overhaul. Notably, Humana's insurance segment benefit ratio improved to 93.7%, better than its guidance of just above 94%. In addition to these achievements, the company raised its full-year adjusted earnings per share forecast to at least $9.50, up from a previous expectation of $9.00. This success highlights Humana's effective adaptation strategies and sets the stage for further growth in the Medicare Advantage sector.
Turnaround in Medicare Advantage Ratings
One of the critical factors in Humana's resurgence is its improvement in Medicare Advantage plan ratings. Previously, only 20% of its members were enrolled in plans rated four stars or higher, a situation that significantly impacted revenue potential. However, updated Medicare star ratings in October 2026 have shown substantial progress, placing 95% of Humana’s enrollments in high-rated plans. This achievement poses lucrative opportunities, as quality bonuses for Medicare Advantage plans are projected at $13.4 billion in 2026, with Humana potentially accruing $4.8 billion by 2028.
Strategic Partnerships and Growth
Humana has also strengthened its position through strategic partnerships and expansion in its health services. The CenterWell division reported a 30% increase in primary care patients, reflecting a revenue jump from $5.9 billion to $7.2 billion. To enhance financial efficiency, Humana collaborated with HPS, now a BlackRock entity. CEO Jim Rechtin emphasized that these strategic realignments are in line with their objectives to exceed growth targets and optimize benefit ratios, leveraging new membership growth projected for 2027.
Enrollment Trends and Market Dynamics
The increase in individual Medicare Advantage enrollment, climbing 25% year-over-year, indicates Humana's evolving market influence. This surge, equating to nearly one million additional members, has led to greater healthcare utilization, particularly among older demographics. To maintain momentum, Humana strategically exited certain lower-rated plans affecting approximately 600,000 members, a move intended to refine their ratings and enhance member service quality.
Commission Structures and Broker Relationships
Humana’s performance is supported by strong broker relationships, a critical aspect in a market where trends favor larger carriers. Notably, the Centers for Medicare & Medicaid Services (CMS) has established 2027 initial Medicare Advantage commission rates at $725 per member, with renewals at $363. These figures provide a framework for Humana's future broker compensation policies, which remain pivotal as new performance ratings and market consolidation trends emerge.
| Aspect | 2023 | 2026 |
|---|---|---|
| Revenue | $32.6 billion | $41.2 billion |
| Medicare Advantage Ratings |
20% over 4 stars | 95% over 4 stars |
| CenterWell Revenue |
$5.9 billion | $7.2 billion |
As Humana continues to refine its business strategies with enhanced broker compensations, collaborations, and member services, its ability to adapt to industry dynamics will be fundamental in securing long-term growth and stability within the competitive Medicare Advantage market.